Originally published April 6 2011
Study helps confirm effectiveness of intravenous vitamin C in fighting cancer
by Ethan A. Huff, staff writer
(NaturalNews) A new open-access, collaborative study published in the Journal of Translational Medicine provides a credible, scientific rationale for the use of intravenous vitamin C as a treatment for cancer. Citing 246 references and supported by both oncologists and alternative medicine practitioners, the study highlights the scientific successes involving the use of intravenous vitamin C to improve immunity, help prevent cachexia, and boost overall quality of life for cancer patients.
"Currently there is a great divide in the way intravenous vitamin C is viewed," said Thomas Ichim, a board member of the Riordan Clinic and first author of the publication. "On the one hand, you have alternative medicine practitioners who have been claiming very interesting results in practical treatment of cancer patients, but cannot explain any molecular rationale for its use or potential effects. On the other hand you have a great amount of scientific literature supporting possible relevance of this approach in cancer. This paper is a significant step towards closing the divide."
Among its various findings, the study suggests that ascorbic acid, an isolated form of vitamin C, may help to protect endothelial cells from chronic stress. Several sources cited in the study also suggest that cancer patients generally lack adequate vitamin C levels, for which higher levels of disease-causing inflammation are a result. Cited references in the study also showed that high-dose vitamin C is even linked to actually stopping the growth of tumors and causing them to shrink.
The Riordan Clinic-promoted study specifically differentiates between oral and intravenous vitamin C treatments, suggesting that only the latter has been proven effective in cancer treatment. Since the body is only capable of assimilating so much vitamin C at a time orally, it is difficult to consume enough in this manner to effectively treat serious diseases. However, previous studies confirm the effective of high-dose intravenous vitamin C in disease treatment.
A 1935 study out of Columbia University found that high-dose vitamin C helps to prevent polio, while another from the same year showed it helps treat diphtheria. A study published a few years later in the Journal of Southern Medicine and Surgery found that high-dose vitamin C can help cure viral pneumonia. And various other studies have confirmed that high-dose vitamin C is capable of treating kidney stones and heart disease as well (http://www.naturalnews.com/028396_vitamin_C_...).
The US Food and Drug Administration (FDA), meanwhile, has been busy trying to outlaw intravenous vitamin C as a legal disease treatment. Back in January, the Alliance for Natural Health announced that the FDA had begun trying to criminally prosecute manufacturers of intravenous vitamin C therapies (http://www.naturalnews.com/030936_vitamin_C_...).
Sources for this story include:
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml